List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Insomnia Therapy Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Insomnia Therapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Insomnia Therapy Market Size for the Year 2017-2028
1.2.2 Global Insomnia Therapy Market Size for the Year 2017-2028
1.3 Insomnia Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Insomnia Therapy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Insomnia Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Insomnia Therapy Market Dynamics
1.4.1 Insomnia Therapy Industry Trends
1.4.2 Insomnia Therapy Market Drivers
1.4.3 Insomnia Therapy Market Challenges
1.4.4 Insomnia Therapy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Insomnia Therapy by Type
2.1 Insomnia Therapy Market Segment by Type
2.1.1 Non-pharmacological Therapy
2.1.2 Pharmacological Therapy
2.2 Global Insomnia Therapy Market Size by Type (2017, 2022 & 2028)
2.3 Global Insomnia Therapy Market Size by Type (2017-2028)
2.4 United States Insomnia Therapy Market Size by Type (2017, 2022 & 2028)
2.5 United States Insomnia Therapy Market Size by Type (2017-2028)
3 Insomnia Therapy by Application
3.1 Insomnia Therapy Market Segment by Application
3.1.1 Hospital
3.1.2 Ambulatory Surgical Center
3.1.3 Home Care
3.2 Global Insomnia Therapy Market Size by Application (2017, 2022 & 2028)
3.3 Global Insomnia Therapy Market Size by Application (2017-2028)
3.4 United States Insomnia Therapy Market Size by Application (2017, 2022 & 2028)
3.5 United States Insomnia Therapy Market Size by Application (2017-2028)
4 Global Insomnia Therapy Competitor Landscape by Company
4.1 Global Insomnia Therapy Market Size by Company
4.1.1 Top Global Insomnia Therapy Companies Ranked by Revenue (2021)
4.1.2 Global Insomnia Therapy Revenue by Player (2017-2022)
4.2 Global Insomnia Therapy Concentration Ratio (CR)
4.2.1 Insomnia Therapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Insomnia Therapy in 2021
4.2.3 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Insomnia Therapy Headquarters, Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Insomnia Therapy Headquarters and Area Served
4.3.2 Global Insomnia Therapy Companies Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Insomnia Therapy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Insomnia Therapy Market Size by Company
4.5.1 Top Insomnia Therapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Insomnia Therapy Revenue by Players (2020, 2021 & 2022)
5 Global Insomnia Therapy Market Size by Region
5.1 Global Insomnia Therapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Insomnia Therapy Market Size by Region (2017-2028)
5.2.1 Global Insomnia Therapy Market Size by Region: 2017-2022
5.2.2 Global Insomnia Therapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Insomnia Therapy Market Size YoY Growth 2017-2028
6.1.2 North America Insomnia Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Insomnia Therapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Insomnia Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Insomnia Therapy Market Size YoY Growth 2017-2028
6.3.2 Europe Insomnia Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Insomnia Therapy Market Size YoY Growth 2017-2028
6.4.2 Latin America Insomnia Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Insomnia Therapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Insomnia Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Company Details
7.1.2 Merck & Co. Business Overview
7.1.3 Merck & Co. Insomnia Therapy Introduction
7.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2017-2022)
7.1.5 Merck & Co. Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Details
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Insomnia Therapy Introduction
7.2.4 Sanofi Revenue in Insomnia Therapy Business (2017-2022)
7.2.5 Sanofi Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Details
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Insomnia Therapy Introduction
7.3.4 Pfizer Revenue in Insomnia Therapy Business (2017-2022)
7.3.5 Pfizer Recent Development
7.4 Takeda Pharmaceutical Company Ltd.
7.4.1 Takeda Pharmaceutical Company Ltd. Company Details
7.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
7.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2017-2022)
7.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
7.5 Purdue Pharmaceuticals L.P.
7.5.1 Purdue Pharmaceuticals L.P. Company Details
7.5.2 Purdue Pharmaceuticals L.P. Business Overview
7.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
7.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2017-2022)
7.5.5 Purdue Pharmaceuticals L.P. Recent Development
7.6 Eisai, Co. Ltd.
7.6.1 Eisai, Co. Ltd. Company Details
7.6.2 Eisai, Co. Ltd. Business Overview
7.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
7.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2017-2022)
7.6.5 Eisai, Co. Ltd. Recent Development
7.7 Meda Consumer Healthcare
7.7.1 Meda Consumer Healthcare Company Details
7.7.2 Meda Consumer Healthcare Business Overview
7.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
7.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2017-2022)
7.7.5 Meda Consumer Healthcare Recent Development
7.8 Pernix Therapeutics
7.8.1 Pernix Therapeutics Company Details
7.8.2 Pernix Therapeutics Business Overview
7.8.3 Pernix Therapeutics Insomnia Therapy Introduction
7.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2017-2022)
7.8.5 Pernix Therapeutics Recent Development
7.9 Vanda Pharmaceuticals
7.9.1 Vanda Pharmaceuticals Company Details
7.9.2 Vanda Pharmaceuticals Business Overview
7.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
7.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2017-2022)
7.9.5 Vanda Pharmaceuticals Recent Development
7.10 ECR Pharmaceuticals
7.10.1 ECR Pharmaceuticals Company Details
7.10.2 ECR Pharmaceuticals Business Overview
7.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
7.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2017-2022)
7.10.5 ECR Pharmaceuticals Recent Development
7.11 Fidia Farmaceutici
7.11.1 Fidia Farmaceutici Company Details
7.11.2 Fidia Farmaceutici Business Overview
7.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
7.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2017-2022)
7.11.5 Fidia Farmaceutici Recent Development
7.12 Dainippon Sumitomo
7.12.1 Dainippon Sumitomo Company Details
7.12.2 Dainippon Sumitomo Business Overview
7.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
7.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2017-2022)
7.12.5 Dainippon Sumitomo Recent Development
7.13 Biocodex
7.13.1 Biocodex Company Details
7.13.2 Biocodex Business Overview
7.13.3 Biocodex Insomnia Therapy Introduction
7.13.4 Biocodex Revenue in Insomnia Therapy Business (2017-2022)
7.13.5 Biocodex Recent Development
7.14 Eli Lilly and Company
7.14.1 Eli Lilly and Company Company Details
7.14.2 Eli Lilly and Company Business Overview
7.14.3 Eli Lilly and Company Insomnia Therapy Introduction
7.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2017-2022)
7.14.5 Eli Lilly and Company Recent Development
7.15 Ebb Therapeutics
7.15.1 Ebb Therapeutics Company Details
7.15.2 Ebb Therapeutics Business Overview
7.15.3 Ebb Therapeutics Insomnia Therapy Introduction
7.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2017-2022)
7.15.5 Ebb Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
